Fingerprint
Dive into the research topics where Claudia Cerella is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Bone marrow tumor microenvironment profiling predicts distinct immunosuppressive phenotypes and immunotherapy potential in AML patients
da Cruz, L. C., Lee, Y., Paik, J. Y., Park, J., Diederich, M. & Cerella, C., Aug 2025, In: Biomedicine and Pharmacotherapy. 189, 118287.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus) -
Martinostat as a novel HDAC inhibitor to overcome tyrosine kinase inhibitor resistance in chronic myeloid leukemia
Yang, H., Li, V., Park, S. J., Cheon, S. W., Lorant, A., Mazumder, A., Lee, J. Y., Orlikova-Boyer, B., Cerella, C., Christov, C., Kirsch, G., Olberg, D. E., Bormans, G., Kang, H. J., Han, B. W., Schnekenburger, M. & Diederich, M., 16 Jul 2025, In: Clinical Epigenetics. 17, 1, 27 p., 125.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
Tetrahydrobenzimidazole TMQ0153 targets OPA1 and restores drug sensitivity in AML via ROS-induced mitochondrial metabolic reprogramming
Park, S. J., Cerella, C., Kang, J. M., Byun, J., Kum, D., Orlikova-Boyer, B., Lorant, A., Schnekenburger, M., Al-Mourabit, A., Christov, C., Lee, J., Han, B. W. & Diederich, M., 7 Apr 2025, In: Journal of Experimental and Clinical Cancer Research. 44, 1, 28 p., 114.Research output: Contribution to journal › Article › Research › peer-review
Open Access10 Citations (Scopus) -
TP53-agnostic lethality through combined pan-HDAC and CDK inhibition in acute myeloid leukemia
Pottier, A., Park, S., Lee, Y., Liccardo, F., Yang, H., Park, J., Lorant, A., Schnekenburger, M., Brusa, D., Li, V., Valente, S., Mai, A., Skuli, S. J., Carroll, M., Boettcher, S., Sarry, J. E., Cerella, C., Morceau, F. & Diederich, M., 28 Nov 2025, In: Cancer Letters. 633, 218011.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation
Orlikova-Boyer, B., Lorant, A., Gajulapalli, S. R., Cerella, C., Schnekenburger, M., Lee, J. Y., Paik, J. Y., Lee, Y., Siegel, D., Ross, D., Han, B. W., Nguyen, T. K. Y., Christov, C., Kang, H. J., Dicato, M. & Diederich, M., Dec 2024, In: Biomarker Research. 12, 1, 47.Research output: Contribution to journal › Article › Research › peer-review
Open Access7 Citations (Scopus)